Subject: FW: COVIFOR - HETERO INPUTS RE: From Archil Dzuliashvili, Ambassador of Georgia
From: Archil Dzuliashvili <[email-masked]>
To: "[email-masked]" <[email-masked]>
Date: Fri, 09 Oct 2020 06:27:46 +0000

From: Vinay Dixit [mailto:[email-masked]]

Sent: Friday, October 9, 2020 11:30 AM

To: Archil Dzuliashvili

Subject: COVIFOR - HETERO INPUTS RE: From Archil Dzuliashvili, Ambassador of Georgia

Dear H.E Mr Archil,

AS discussed Product information and FDA authorisation for your kind references.

https://www.fda.gov/media/137566/download

2. FDA broadens emergency use authorization of Remdesivir after positive results in Moderate COVID-19 patients after 5 day course compared to standard of care published in JAMA. The new authorization recommends Remdesivir to be included
as treatment for all hospitalized adult and paediatric patients with suspected or laboratory-confirmed COVID-19,
Irrespective of their severity of disease. This new authorization broadens the patient profile for
COVIFOR and reiterates the need for a treatment option with faster recovery considering the rapid rise in new cases.

Press release :
https://www.fda.gov/news-events/press-announcements/covid-19-update-fda-broadens-emergency-use-authorization-veklury-remdesivir-include-all-hospitalized

We are really hopeful that we utilize the opportunity to the maximum and broadens our COVIFOR success.

From: Archil Dzuliashvili <[email-masked]>

Sent: 08 October 2020 20:46

To: Vinay Dixit <[email-masked]>

Subject: From Archil Dzuliashvili, Ambassador of Georgia

Dear Mr. Vinay Dixit,

I hope you are already informed about the urgent inquiry from the Government of Georgia regarding the procurement of Remdesivir from HETERO Labs Ltd.

Georgia, similar to other countries, is facing significant challenges related to COVID-19 pandemic. Consequently, the Government of Georgia is taking all necessary measures to efficiently
respond to the outbreak and prevent the dramatic spread of the diseases.

Due to the deterioration of the epidemiological situation, the Government of Georgia is committed of using all current opportunities, including engagement in the study of Remdesivir for the
treatment of the patients with the severe acute respiratory syndrome of COVID-19 to avoid fatal outcomes in the infected patients as far as possible.

In this regard,  Georgia is urgently looking forward to procurer generic form of Remdesivir, initially sufficient for 500 eligible patients. We kindly request you to positively consider the
mentioned matter and provide with the product price as well as terms and conditions of delivery as early as possible.

I do hope that successful cooperation will be established between the respected HETERO Labs Ltd and Georgia, which will significantly contribute to the globally coordinated efforts to defeat
the Coronavirus.

I am attaching a letter of Minister of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia address to you and looking forward to hearing
from you soon.

My mob. number is +91 995 847 44 22

Best regards,

Archil Dzuliashvili

Ambassador

Embassy of Georgia

169, Jor Bagh, 110003

New Delhi, India

Tel: +91 11 405 01 424

+91 11 49 49 6000

www.india.mfa.gov.ge

Confidentiality Notice:

This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e-mail address.
If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error, please delete the message
and any attachments
from your Inbox.